UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korea eases criteria for discharging cured Covid-19 patients
The government relaxed criteria for discharging the coronavirus patients fr...
by Shim Hyun-tai
|
2020-06-25 18:23
라인
Gencurix scores FDA nod for upgraded Covid-19 test kit
Gencurix, a diagnostics biotech company, said it has won emergency use appr...
by Shim Hyun-tai
|
2020-06-25 18:23
라인
Alteogen signs $3.8-billion tech transfer deal with a global pharma
Alteogen has signed a $3.87 billion tech transfer contract with a global ph...
by Shim Hyun-tai
|
2020-06-25 16:19
라인
‘Stool can increase accuracy of Covid-19 tests in adolescents’
A research team at Seoul National University Boramae Hospital has discovere...
by Lee Han-soo
|
2020-06-25 16:19
라인
SNUH to test Covid-19 drug candidate remdesivir in follow-up study
The Seoul National University Hospital (SNUH) said it would conduct a follo...
by Choi Gwang-seok
|
2020-06-25 15:30
라인
Stock exchange adds reason to review SillaJen’s listing eligibility
The Korea Exchange’s Kosdaq Market Division said in a public disclosure on ...
by Kim chan-hyuk
|
2020-06-25 15:30
라인
‘Use NEWS score system to detect high-risk Covid-19 patients early’
To reduce deaths caused by Covid-19 without treatment and vaccine, it is es...
by Song Soo-youn
|
2020-06-25 15:07
라인
Hanmi, Novartis in patent dispute over diabetes drug
A court is to decide on the legal dispute between Hanmi Pharmaceutical and ...
by Kim Yun-mi
|
2020-06-25 13:59
라인
‘Daily community spreads remain at dangerous level of 30’
New virus cases fell back to below 30 Thursday from 51 the previous day, bu...
by Lee Han-soo
|
2020-06-25 12:32
라인
[Reporter's Notebook] Drugmakers introduce creative PR formats amid Covid-19
More than five months have passed since Korea began battling against the Co...
by Lee Han-soo
|
2020-06-25 11:17
라인
CancerRop wins manufacturing permit for Covid-19 diagnostic kit
CancerRop said that the Ministry of Food and Drug Safety has granted a manu...
by Lee Han-soo
|
2020-06-24 18:15
라인
Ticagrelor monotherapy lowers bleeding risk in coronary syndrome patients
A research team has found that stopping dual antiplatelet therapy (DAPT) an...
by Shim Hyun-tai
|
2020-06-24 18:03
라인
Hanmi Science Presents 6 Great Visions for Post COVID-19
Hanmi Science with the gene of 'Innovation' presented six great vis...
by Lee Han-soo
|
2020-06-24 18:02
라인
Samsung Biologics gets CMO orders of ₩1.7 trillion in H1
Samsung Biologics said that it has signed a letter of intent for a contract...
by Lee Han-soo
|
2020-06-24 15:54
라인
‘Choose home-cooked meals over fast food amid Covid-19’
People need to pay more attention to nutrition and physical activities to m...
by Choi Gwang-seok
|
2020-06-24 15:53
라인
Chong Kun Dang most attention-gathering drugmaker amid Covid-19
People paid most attention to Chong Kun Dang among the top 10 local pharmac...
by Kim Eun-young
|
2020-06-24 14:54
라인
‘Live liver donors’ 10-year mortality remains at 0.9%’
The popular medical drama “Hospital Playlist” depicted many cases of living...
by Choi Gwang-seok
|
2020-06-24 14:35
라인
Korea keeps fighting Covid-19 on local, foreign fronts
New virus cases in Korea rose back to 51 on Wednesday, as the nation saw co...
by Lee Han-soo
|
2020-06-24 12:11
라인
GSK sure about Dovato’s changing HIV treatment paradigm
GSK is pioneering a new field in the human immunodeficiency virus (HIV) mar...
by Lee Han-soo
|
2020-06-24 12:11
라인
Hanmi to sell prostatism drug in Japan
Hanmi Pharmaceutical said Tuesday that it would release 2.5- and 5- milligr...
by Shim Hyun-tai
|
2020-06-23 18:17
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top